Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lianyun Zhao

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Organic Letters|April 21, 2025
CuOTf(Tol)<sub>1/2</sub>-Catalyzed O-Trifluoroethylation of Alcohols with 2,2,2-TrifluorodiazoethaneLeyi Tao, Zhiyu Lei, Lianyun Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Design, synthesis and SAR of thienopyridines as potent CHK1 inhibitorsLianyun Zhao, Yingxin Zhang, Chaoyang Dai, et al.
The Journal of Organic Chemistry|May 5, 2020
Selective N7 Alkylation of 7-AzaindazolesZhiyu Lei, Jianming Bao, Chen Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2013
Potency switch between CHK1 and MK2: discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitorsZhaoyang Meng, Jeffrey P Ciavarri, Andrew McRiner, et al.
Journal of Medicinal Chemistry|February 8, 2002
Structural basis of RasGRP binding to high-affinity PKC ligandsSuo-Bao Rong, Istvan J Enyedy, Lixin Qiao, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2013
Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitorsXiaohua Huang, Cliff C Cheng, Thierry O Fischmann, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of MalariaManuel de Lera Ruiz, Paola Favuzza, Zhuyan Guo, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitorYongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitorsChaoyang Dai, Dansu Li, Janeta Popovici-Muller, et al.
Cell Host & Microbe|February 29, 2020
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Organic Letters|April 21, 2025
CuOTf(Tol)<sub>1/2</sub>-Catalyzed O-Trifluoroethylation of Alcohols with 2,2,2-TrifluorodiazoethaneLeyi Tao, Zhiyu Lei, Lianyun Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Design, synthesis and SAR of thienopyridines as potent CHK1 inhibitorsLianyun Zhao, Yingxin Zhang, Chaoyang Dai, et al.
The Journal of Organic Chemistry|May 5, 2020
Selective N7 Alkylation of 7-AzaindazolesZhiyu Lei, Jianming Bao, Chen Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2013
Potency switch between CHK1 and MK2: discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitorsZhaoyang Meng, Jeffrey P Ciavarri, Andrew McRiner, et al.
Journal of Medicinal Chemistry|February 8, 2002
Structural basis of RasGRP binding to high-affinity PKC ligandsSuo-Bao Rong, Istvan J Enyedy, Lixin Qiao, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2013
Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitorsXiaohua Huang, Cliff C Cheng, Thierry O Fischmann, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of MalariaManuel de Lera Ruiz, Paola Favuzza, Zhuyan Guo, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitorYongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitorsChaoyang Dai, Dansu Li, Janeta Popovici-Muller, et al.
Cell Host & Microbe|February 29, 2020
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, et al.
Pageof 2